Clinical Trial Update: Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS [Phase 4]

View source ↗

Summary

Phase 4 trial assessing co-administration of low-dose hCG with GnRH agonist trigger for prevention of OHSS; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• hCG (human chorionic gonadotropin)

Snippet

Sponsor: UConn Health | Conditions: Ovarian Hyperstimulation Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2017-09-25